Safety in mind as Prescient Therapeutics develops next-generation CAR-T platform
Tragedy struck the CAR-T space this month with a US company halting a trial of...
Tragedy struck the CAR-T space this month with a US company halting a trial of...
Clinical stage oncology company Prescient Therapeutics (ASX:PTX) has announced another crucial step forward in the development of...
he federal government’s “patent box” initiative caught the eye of Australia’s biotech sector in Tuesday...
Biotech company Prescient Therapeutics (ASX:PTX) had an important announcement for the market this morning, after strengthening its...
With the number of days left to file March quarterly reports running a little short...
Melbourne biotech company Prescient Therapeutics (ASX:PTX) says a clinical trial evaluating its PTX-200 drug candidate to treat...
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each...
There are several ASX stocks fighting cancer but only a few are addressing blood cancers....
Special Report: A form of immunotherapy that involves modifying a patient’s white blood cells so...
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each...

This investor centre was built by Reach Markets
©2026 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.